Image

High-Flow Nasal Cannula vs. NIV After Extubation in Children Undergoing Heart Surgery

High-Flow Nasal Cannula vs. NIV After Extubation in Children Undergoing Heart Surgery

Recruiting
18 years and younger
All
Phase N/A

Powered by AI

Overview

High-Flow Nasal Cannula vs. NIV After Extubation in Children Undergoing Heart Surgery

Description

This study aims to compare the extubation success rate between the use of High Flow Nasal Cannula (HFNC) and Non-Invasive Ventilation (NIV) in pediatric patients post-cardiac surgery at the Cipto Mangunkusumo National General Hospital. Additionally, this study seeks to identify factors influencing extubation failure in high-risk patient populations, compare CICU length of stay, sedation usage and COMFORT scale between patients receiving HFNC and those receiving NIV.

Eligibility

Inclusion Criteria:

  • Patients under 18 years of age.
  • Post-cardiac surgery patients in the CICU of Cipto Mangunkusumo National General Hospital
  • Patients at high risk of extubation failure (e.g., young age, open sternotomy, mechanical ventilation >48 hours).
  • Patients who pass the extubation readiness test and spontaneous breathing trial.

Exclusion Criteria:

  • Diaphragmatic paralysis.
  • Decreased consciousness.
  • Neuromuscular disease.
  • Pneumothorax without drainage.
  • Airway obstruction.
  • Patients with a tracheostomy.
  • Unplanned extubation.
  • Patient received PEEP (Positive End-Expiratory Pressure) >7 prior to extubation

Study details
    Heart Defects
    Congenital
    Intensive Care Units
    Pediatric
    Respiration
    Artificial
    Extubation

NCT07059689

Indonesia University

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.